Laryngeal aspergilloma: a complication of inhaled fluticasone therapy for asthma
- PMID: 25530858
- PMCID: PMC4263490
- DOI: 10.1002/rcr2.70
Laryngeal aspergilloma: a complication of inhaled fluticasone therapy for asthma
Abstract
Primary laryngeal aspergillosis in immunocompetent patients is rare. We describe a case of a 59-year-old woman with laryngeal aspergillosis thought to be secondary to long-term inhaled fluticasone therapy. Laryngeal aspergillosis may be an underrecognized complication of inhaled corticosteroid therapy.
Keywords: Aspergillosis; asthma; fluticasone; laryngeal; vocal cords.
Figures
References
-
- Colice GL. New developments in inhaled corticosteroids. Allergy Asthma Proc. 2006;27:332–340. - PubMed
-
- Liu YC, Zhou SH. Ling L. Aetiological factors contributing to the development of primary laryngeal aspergillosis in immunocompetent patients. J. Med. Microbiol. 2010;59:1250–1253. - PubMed
-
- Naseer R, Buck LJ, Small M, et al. An unusual case of hoarseness of voice related to corticosteroid treatment. Respiratory Med. Case Rep. 2011;4:170–171.
LinkOut - more resources
Full Text Sources
Other Literature Sources
